Precision Business Insights

Portfolio

Research Reports

SELECT LICENSE TYPE
Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner

Why Precision Business Insights?

  • Pre and Post Sale Support

    Get in touch with our industry experts to resolve your research queries before and after buying the report. Avail free 60 minutes analyst tele-call to get additional market information before and after purchase

  • Special Pricing and Discounts

    Avail special pricing for the purchase of report sections,regional insights, and historical data. Discounts for government bodies, research institutes, universities, NGO’s and start-up’s

  • In-depth Market Analysis

    Our research reports provides holistic market information with 360 degree analysis. We adopt 3 pronged strategy to analyze the market i.e. Secondary research , primary research, and expert validation

  • Accurate and Reliable Market Data

    Utmost focus on delivering accurate and reliable research reports. We adopt internally developed data mining tools to eliminate any data errors

  • NICHE AND GROWTH MARKETS EXPERTISE

    Proven expertise in delivering new and emerging markets product and technology advancements. We provide market information across the developed and emerging markets

  • ADHERING TO QUICK DELIVERY TIME LINES

    We provide impeccable research reports in quick turnaround time

Clinical Research Services Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023


 

Available formats:    

StumbleUponEmail

Clinical research services market: Clinical research is a branch of healthcare that studies whether a medical strategy, medicine, medical device, diagnostics and treatment regimes is safe and effective for human use. Clinical research may contribute to treatment, prevention, diagnosis or relieving certain symptoms of disease or condition. Clinical research is carried out with a pool of patients or people under study condition. Clinical research is a broad term which includes many research studies such as treatment, prevention, diagnostic, screening, genetic, epidemiological and clinical trial studies.

 

Global Market Outline: Clinical Research Services Market

 

Global clinical research services market is driven by increased burden of chronic diseases such as HIV, cancer and cardio vascular diseases, which requires huge investments. Pharmaceutical and biotechnological companies outsource their clinical research activities to clinical research service organizations to reduce the cost and regulatory burdens. In addition, enormous growth in biopharmaceutical segment, discovery of the new drugs through innovation and increase in clinical trials are expected to boost the clinical research services market over the forecast period. However, increase in clinical research costs, stringent regulatory procedures and ethical issues are hindering the clinical research services market.

 

Clinical research services market has been segmented based on type of service, therapeutic area, end user, and region

 

Based on type of service, clinical research services market is segmented into

  • Treatment Research
  • Prevention Research
  • Diagnostic Research
  • Screening Research
  • Quality of LifeResearch
  • Genetic studies
  • Epidemiological studies
  • Clinical Trials
  • Others

 

Base on disease area, clinical research services market is segmented into

  • Oncology
  • Central Nervous System Disorders
  • Cardio Vascular Disorders
  • Diabetes
  • Infectious Diseases
  • Others

 

Based on end-user, clinical research services market is segmented into

  • Pharmaceutical Companies
  • Biotechnological Companies
  • Research Organizations
  • Others

 

Clinical research services market is at steady stage of growth. The market is expected to grow at a significant rate during the forecast period. Market players are expanding their markets by offering various services and collaborations. For instance in June 2017, PAREXEL International Corporation, a leading global biopharmaceutical services organization, collaborated with Sanofi to advance the use of wearable devices to transform the collection of data in clinical trials. Moreover, In order to maintain market position, companies adopting mergers and acquisitions as their key strategies. For instance, in May, 2017 and inVentiv Health, Inc. and INC Research Holdings, Inc., announced a definitive merger agreement to create a leading biopharmaceutical solutions organization. Similarly, in April 2016, Charles River Laboratories acquired WIL Research to enhance its global footprint, scientific capabilities, and access to growing market segments.

 

Geographically clinical research services market has been segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America clinical research services market expected to be leading clinical research services market owing to factors such as favourable regulations, developed infrastructure, increase in research and development activities and availability of pool of patients. Europe clinical research services market expected to grow at significant rate owing to increase in R&D activities by pharma and biotechnological companies and favourable regulatory environment and government policies. Asia Pacific region clinical research services market is expected to be fastest growing owing to developing regulatory policies, low cost of the research and availability of a large number of patients.

 

Some of the players in Clinical Research Services market are Laboratory Corporation Of America Holdings (U.S.), Quintiles Transnational Holdings Inc. (U.S.), PAREXEL International Corporation (U.S.), ICON Plc (Ireland), PRA Health Sciences, Inc. (U.S.), InVentiv Health Inc. (U.S.), Wuxi AppTec (Cayman) Inc. (China), Pharmaceutical Product Development, LLC (U.S.), INC Research Holdings Inc. (U.S.), and Charles River Laboratories International Inc. (U.S.), to name a few.

 

  • In October 2015, WuXi PharmaTech (Cayman) Inc. and Gilead Sciences, Inc., strategically partnered in conducting analytical and stability studies of small-molecule new chemical entities to support global marketing applications and commercial products.

 

Report Outline:

 

  • The report provides granular level information about the market size, regional market share and forecast from 2017-2023
  • The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
  • The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
  • The report tracks recent innovations, key developments and startup’s details that are working in the industry
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

1. Executive Summary
2. Global Clinical Research Services Market Introduction
2.1. Global Clinical Research Services Market – Taxonomy
2.2. Global Clinical Research Services Market –Definitions
2.2.1. Service Type
2.2.2. Disease Area
3. Global Clinical Research Services Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Clinical Research Services Market Dynamic Factors – Impact Analysis
4. Global Clinical Research Services Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Clinical Research Services Market, By Service Type, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1. Treatment Research
5.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Prevention Research
5.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Diagnostic Research
5.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Screening Research
5.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Quality of Life Research
5.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Genetic Studies
5.6.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
5.7. Epidemiological Studies
5.7.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.7.3. Market Opportunity Analysis
5.8. Clinical Trials
5.8.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.8.3. Market Opportunity Analysis
5.9. Others
5.9.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.9.3. Market Opportunity Analysis
6. Global Clinical Research Services Market, By Disease Area, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.1. Oncology
6.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. CNS Disorders
6.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Cardio Vascular Disorders
6.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Diabetes
6.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Infectious Diseases
6.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Others
6.6.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
7. Global Clinical Research Services Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.1. North America
7.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Clinical Research Services Market – Opportunity Analysis Index, By Service Type, By Disease Area, and Region, 2018 – 2024
8. North America Clinical Research Services Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.1. Service Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.1.1. Treatment Research
8.1.2. Prevention Research
8.1.3. Diagnostic Research
8.1.4. Screening Research
8.1.5. Quality of LifeResearch
8.1.6. Genetic studies
8.1.7. Epidemiological studies
8.1.8. Clinical Trials
8.1.9. Others
8.2. Disease Area Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.2.1. Oncology
8.2.2. Central Nervous System Disorders
8.2.3. Cardio Vascular Disorders
8.2.4. Diabetes
8.2.5. Infectious Diseases
8.2.6. Others
8.3. Country Analysis 2016 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. U.S.
8.3.2. Canada
8.4. North America Clinical Research Services Market – Opportunity Analysis Index, By Service Type, By Disease Area, and Country, 2018 – 2024
8.5. North America Clinical Research Services Market Dynamics – Trends
9. Europe Clinical Research Services Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
9.1. Service Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Treatment Research
9.1.2. Prevention Research
9.1.3. Diagnostic Research
9.1.4. Screening Research
9.1.5. Quality of LifeResearch
9.1.6. Genetic studies
9.1.7. Epidemiological studies
9.1.8. Clinical Trials
9.1.9. Others
9.2. Disease Area Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Oncology
9.2.2. Central Nervous System Disorders
9.2.3. Cardio Vascular Disorders
9.2.4. Diabetes
9.2.5. Infectious Diseases
9.2.6. Others
9.3. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Russia
9.3.7. Poland
9.3.8. Rest of Europe
9.4. Europe Clinical Research Services Market – Opportunity Analysis Index, By Service Type, By Disease Area, and Country, 2018 – 2024
9.5. Europe Clinical Research Services Market Dynamics – Trends
10. Asia-Pacific Clinical Research Services Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
10.1. Service Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Treatment Research
10.1.2. Prevention Research
10.1.3. Diagnostic Research
10.1.4. Screening Research
10.1.5. Quality of LifeResearch
10.1.6. Genetic studies
10.1.7. Epidemiological studies
10.1.8. Clinical Trials
10.1.9. Others
10.2. Disease Area Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Oncology
10.2.2. Central Nervous System Disorders
10.2.3. Cardio Vascular Disorders
10.2.4. Diabetes
10.2.5. Infectious Diseases
10.2.6. Others
10.3. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. ASEAN
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Clinical Research Services Market – Opportunity Analysis Index, By Service Type, By Disease Area, and Country, 2018 – 2024
10.5. Asia-Pacific Clinical Research Services Market Dynamics – Trends
11. Latin America Clinical Research Services Market Analysis, 2012 – 2012 – 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
11.1. Service Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Treatment Research
11.1.2. Prevention Research
11.1.3. Diagnostic Research
11.1.4. Screening Research
11.1.5. Quality of LifeResearch
11.1.6. Genetic studies
11.1.7. Epidemiological studies
11.1.8. Clinical Trials
11.1.9. Others
11.2. Disease Area Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Oncology
11.2.2. Central Nervous System Disorders
11.2.3. Cardio Vascular Disorders
11.2.4. Diabetes
11.2.5. Infectious Diseases
11.2.6. Others
11.3. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Argentina
11.3.4. Venezuela
11.3.5. Rest of Latin America
11.4. Latin America Clinical Research Services Market – Opportunity Analysis Index, By Service Type, By Disease Area, and Country, 2018 – 2024
11.5. Latin America Clinical Research Services Market Dynamics – Trends
12. Middle East and Africa Clinical Research Services Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
12.1. Service Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Treatment Research
12.1.2. Prevention Research
12.1.3. Diagnostic Research
12.1.4. Screening Research
12.1.5. Quality of LifeResearch
12.1.6. Genetic studies
12.1.7. Epidemiological studies
12.1.8. Clinical Trials
12.1.9. Others
12.2. Disease Area Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Oncology
12.2.2. Central Nervous System Disorders
12.2.3. Cardio Vascular Disorders
12.2.4. Diabetes
12.2.5. Infectious Diseases
12.2.6. Others
12.3. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Gulf Cooperation Council (GCC) Countries
12.3.2. Israel
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Clinical Research Services Market – Opportunity Analysis Index, By Service Type, By Disease Area, and Country, 2018 – 2024
12.5. MEA Clinical Research Services Market Dynamics – Trends
13. Competition Landscape
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. America Holdings (U.S.)
13.2.2. IQVIA (U.S.)
13.2.3. PAREXEL International Corporation (U.S.)
13.2.4. ICON Plc (Ireland)
13.2.5. PRA Health Sciences, Inc. (U.S.)
13.2.6. Wuxi AppTec (Cayman) Inc. (China)
13.2.7. Pharmaceutical Product Development, LLC (U.S.)
13.2.8. Charles River Laboratories International Inc. (U.S.)
13.2.9. Syneos Health
14. Research Methodology
15. Key Assumptions and Acronyms

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

OR

CALL US ON : 123456789

Avail Discount  Up To 20%

Need more discount on this report?

Call or e-mail us for:

(U.S.) – +1-866-598-1553

Contact SalesTOLL FREE: +1-866-598-1553